IMCC

IM Cannabis Corp.

2.01 USD

Last updated Sep 12, 02:18 UTC

Yesterday HIGH

$1.97

Yesterday LOW

$1.73

52w HIGH

$77.1

52w LOW

$1.73

EPS

-10.20

PE

-0.20

Next Earnings

Nov 12, 2026

Overview News Government Trades Fundamentals

IM Cannabis Corp. stock is down -48.46% since 30 days ago. The next earnings date is Nov 12, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 14.29% of the previous 30 September’s closed higher than August.

Benzinga Insights

Wed Jun 17, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Tue Jun 16, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Avi Kapoor

Tue Jun 16, 2026

Why High Tide Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket

HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open. Other gainers include SLBT, TDIC, IMCC, IVDA, NXTS, CRVO, PAVS, ALBT, and PURR. Losers include RGNT, PRFX, WLDS, SCLX, and CRVO.
Benzinga Insights

Mon Jun 15, 2026

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Newsdesk

Mon Jun 15, 2026

IM Cannabis shares are trading higher amid sympathy with High Tide after the company reported Q2 financial results.
Benzinga Newsdesk

Fri Jun 5, 2026

'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment

https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amending-broad-ban-thats-set-to-take-effect-later-this-year/
Benzinga Newsdesk

Wed Jun 3, 2026

IM Cannabis Announces Closing Of $225K Convertible Note Financing In Private Placement With Institutional Investor
Benzinga Newsdesk

Fri May 29, 2026

"Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana Moment

https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec
Benzinga Insights

Thu May 28, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Newsdesk

Wed May 13, 2026

IM Cannabis Q1 EPS $(0.28) Down From $0.06 YoY, Sales $6.343M Down From $8.708M YoY

IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.28) per share. This is a 566.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $6.343 million in sales

ORCL $147.76 USD

GTBIF GTBIF $0.00 USD

AZN $160.12 USD

GS $1,029.08 USD

DELL $566.53 USD

CSCO $112.19 USD